Search
for
Sort by
Research 361–390 of 1000+
- Microinjury-Induced Tumor Necrosis Factor-α Surge Stimulates Hair Regeneration in Mice
- Medication-induced hair loss: An update
- A biomarker-guided therapeutic map for alopecia: in vivo evidence and clinical implications.
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Alopecia areata – Current understanding and management
- Management of folliculitis decalvans: The EADV task force on hair diseases position statement
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- Psoriasiform skin reaction due to Brazilian keratin treatment
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- New Modalities in the Treatment of Refractory Alopecia Areata
- Alopecia areata: current concepts
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- Poster Presentations at the 28th Joint Meeting of the International Society of Dermatopathology, March 5–6, 2025, Orlando, Florida, USA
- Uncommon Presentation of Pityriasis Rubra Pilaris of the Scalp: Clinical, Trichoscopic, and Histopathologic Features and Review of the Literature
- Proinflammatory cytokines regulate epidermal stem cells in wound epithelialization
- CXCL12+ dermal fibroblasts promote neutrophil recruitment and host defense by recognition of IL-17
- Inflammatory perspectives of polycystic ovary syndrome: role of specific mediators and markers
- A “hair‐raising” history of alopecia areata
- The Tumor Necrosis Factor-α Level in Platelet-Rich Plasma Might Be Associated with Treatment Outcome in Patients with Interstitial Cystitis/Bladder Pain Syndrome or Recurrent Urinary Tract Infection
- Interleukin-15 and Tumor Necrosis Factor-α in Iraqi Patients with Alopecia Areata
- Recent Insight on the Management of Lupus Erythematosus Alopecia
- Drug-induced scarring and permanent alopecia
- Systemic Therapies for Scarring and Non-scarring Alopecia
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- Review of Promising Off-Label Use of Deucravacitinib
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- The JAK/STAT signaling pathway: from bench to clinic
- Organ-Level Quorum Sensing Directs Regeneration in Hair Stem Cell Populations
- Androgen receptor–mediated inhibition of cutaneous wound healing